| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10930949 | Cytotherapy | 2005 | 10 Pages |
Abstract
DC-based VDLN T cells are an important source of anti-tumor effector for adoptive immunotherapy. This study provides a novel and an effective protocol using T-cell adoptive immunotherapy for application in cancer patients; therefore, clinical trials based on this protocol may be warranted.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Z. Liu, H. Fan, Y. Wu, B. (Dr),